- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8531
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,531 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$156.66 | 6.3% | 49.8% | US$49.0b | US$150.23 | PE82.7x | E32.9% | 2.4% | Diversified Financials | ||
AOT | CA$0.16 | -3.0% | -63.6% | CA$113.0m | n/a | PS46.7x | E46.9% | n/a | Materials | ||
CADLR | NOK 70.70 | 0.3% | 88.1% | NOK 24.8b | NOK 81.94 | PS17.2x | E67.8% | n/a | Capital Goods | ||
ZVRA | US$8.06 | 2.7% | 65.8% | US$422.0m | US$18.00 | PS17.9x | E69.5% | n/a | Pharmaceuticals & Biotech | ||
CALTX | SEK 206.40 | 0.1% | 94.9% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
RHM | €487.70 | -6.4% | 94.8% | €21.2b | €616.44 | PE32.5x | E27.7% | 1.2% | Capital Goods | ||
GGP | UK£0.065 | 19.2% | -3.6% | UK£331.4m | n/a | PB6.6x | E48.8% | n/a | Materials | ||
SCOL | SEK 0.15 | 13.2% | -90.5% | SEK 33.9m | n/a | PB0.7x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
AFISH | NOK 45.00 | -3.4% | -48.9% | NOK 1.4b | NOK 81.00 | PS1.5x | E98.9% | n/a | Food, Beverage & Tobacco | ||
GAU | CA$1.95 | -5.3% | 114.3% | CA$506.1m | CA$3.30 | PE38.1x | E31.2% | n/a | Materials | ||
MBTN | CHF 1.55 | 17.1% | -99.4% | CHF 47.7m | CHF 6.03 | PB0.2x | E95.4% | n/a | Semiconductors | ||
RMDA | ج.م2.65 | 3.1% | 76.7% | ج.م4.0b | ج.م4.11 | PE17.6x | E30.2% | 2.5% | Pharmaceuticals & Biotech | ||
NVDA | US$116.00 | -2.6% | 178.8% | US$2.9t | US$148.83 | PE53.7x | E22.3% | 0.03% | Semiconductors | ||
LAVV3 | R$8.29 | -5.1% | 8.7% | R$1.6b | R$12.98 | PE5.9x | E21.1% | 3.4% | Real Estate Management and Development | ||
TGTX | US$24.65 | 3.9% | 169.7% | US$3.5b | US$33.75 | PE37x | E43.5% | n/a | Pharmaceuticals & Biotech | ||
EH | US$11.91 | -2.0% | -32.2% | US$783.5m | US$24.76 | PS21.3x | E81.5% | n/a | Capital Goods | ||
SRPT | US$127.21 | 2.1% | 6.1% | US$12.1b | US$194.36 | PE256.5x | E44.1% | n/a | Pharmaceuticals & Biotech | ||
PLT | AU$0.71 | 9.2% | 104.3% | AU$125.4m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials | ||
MX1 | AU$0.051 | -8.9% | -55.7% | AU$29.7m | n/a | PS1.9x | E86.1% | n/a | Healthcare | ||
A067310 | ₩11,020.00 | -3.8% | -50.8% | ₩664.4b | ₩21,898.55 | PB2.4x | E100.3% | 0.4% | Semiconductors | ||
7096 | JP¥1,655.00 | 1.3% | -35.7% | JP¥17.0b | n/a | PE41.1x | E38.4% | n/a | Healthcare | ||
526 | CN¥49.20 | 1.7% | 86.6% | CN¥6.1b | CN¥70.77 | PE26.8x | E27.1% | n/a | Consumer Services | ||
1269 | CN¥22.09 | -2.6% | -52.2% | CN¥4.3b | CN¥41.16 | PE35.3x | E49.3% | 5.4% | Semiconductors | ||
HTL | PK₨36.77 | -5.0% | 53.8% | PK₨5.1b | PK₨63.60 | PB0.9x | E48.3% | 0% | Capital Goods |